Members of BIHP believe that it is crucial to build a political movement behind Medicare for All, with candidates who are willing to take on the insurance and pharmaceutical industries oversized political influence.
Members of BIHP applauded the bill for its unique enforcement power, which will enable Medicare to reign in the monopoly power of large pharmaceutical companies.
FOR IMMEDIATE RELEASE July 19th, 2018 Contact: Dylan Dusseault email@example.com 727-743-7809 BusinessInitiative.org Business Leaders Applaud Medicare for All Caucus The Business Initiative for Health Policy (BIHP), a group of business owners, economists, former industry insiders, and health policy experts, expressed support for the announcement of the first ever Congressional Medicare for All Caucus. The caucus, which will be chaired by Representatives Pramila Jayapal (D-WA), Keith … Continue reading Business Leaders Support Medicare for All Caucus
“A patchwork of private corporations like insurance companies and PBMs do not have the same power or incentive to negotiate on behalf of the American people as Medicare.”
If we want a system that has universal coverage, is fiscally sustainable, and can withstand the political whims of the White House, we need Medicare for All”.
While we laud any efforts by Congress to insure more Americans, Medicare for All is the only fiscally sustainable way to achieve universal health care.
This is the third film from Executive Producer Richard Master, who is the founder of BIHP and previously produced “Fix It: Healthcare at the Tipping Point” and “Big Pharma: Market Failure”.
“If you even take a cursory glance at accelerating health care price inflation, rising cost sharing for the sick and disabled, and falling life expectancy, it is clearly time for a new approach to financing America’s health care system.
These business leaders, policy experts, medical professionals, and activists have all interacted extensively with different sectors of the healthcare industry, and bring a wide array of experience and perspectives to the table.
“By nominating Alex Azar, Donald Trump is breaking his campaign promise. By confirming him, the Senate is failing their constituents who desperately need affordable prescription drugs.”